Aclaris Therapeutics to Attend Upcoming Investor Conferences
January 02 2019 - 6:00AM
Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led
biopharmaceutical company committed to identifying, developing, and
commercializing innovative therapies to address significant unmet
needs in dermatology and immunology, today announced that
management will attend the following conferences:
- Management will host investor meetings during the 2019 JP
Morgan Healthcare Conference in San Francisco, CA from Monday,
January 7, 2019 through Wednesday, January 9, 2019.
- Dr. Neal Walker, President and Chief Executive Officer, will
present at the 8th Annual Leerink Partners Global Healthcare
Conference in New York, NY on Wednesday, February 27, 2019 at 10:30
AM EST. Management will also host investor meetings on Wednesday,
February 27, 2019.
A live webcast of the 8th Annual Leerink Partners Global
Healthcare Conference presentation may be accessed through the
Company's web site, www.aclaristx.com, on the 'Events and
Presentations' section. An archived version of the presentation
will be available for 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a dermatologist-led
biopharmaceutical company focused on identifying, developing, and
commercializing innovative therapies to address significant unmet
needs in aesthetic and medical dermatology, and immunology.
Aclaris’ focus on market segments with no FDA-approved medications
or where treatment gaps exist has resulted in the first
FDA-approved treatment for raised seborrheic keratoses and several
clinical programs to develop medications for the potential
treatment of common warts, alopecia areata, and vitiligo. For
additional information, please visit www.aclaristx.com and
follow Aclaris on LinkedIn.
Contact:
Aclaris ContactMichael Tung, M.D.Senior Vice President Corporate
Strategy/Investor
Relations484-329-2140mtung@aclaristx.com
Media ContactSheila KennedyVice President, Corporate
Communications484-321-5559media@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2024 to May 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From May 2023 to May 2024